Tactile systems revises 2025 revenue guidance to $309M-$315M amid strategic investments

Stock Information for Tactile Systems Technology Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Tactile Systems Technology Inc.

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors
Tactile Medical to Present at Upcoming Investor Conferences in June
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results
Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025
Tactile Medical Expands Launch of Nimbl(TM) to Include Patients with Lower Extremity Lymphedema

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.